Karnataka DC Launches Real-Time Database For Tapentadol Stocks To Curb Misuse

Bengaluru: The database enables enforcement officers, who must update the portal after collecting stock data from drug distributors every day, tally the demand and supply numbers between wholesalers and retailers and take immediate action if the numbers do not add up, noted Dr Umesh S, State Drugs Controller.

“Until now, we did not have a track of the quantum of the drugs being supplied from wholesalers to retailers. We are doing this so that the daily updated figures might also make chemists think twice before enabling any misuse,” he told DH.

Licence holders can also directly upload their stock details using their firm ID.

“We are monitoring this real time to control the supply of this drug because it is the most-misused among the narcotic drugs and psychotropic substances. At the end of the day, if we are suspecting any distributors, we can cross-check their details and catch them in the act,” a senior official from the department said.

Dr Arun Kandasamy, Psychiatry Professor and Chief, Centre for Addiction Medicine, Nimhans, explained that although Tapentadol is an oral drug, people who overuse the drug administer it to themselves via injections to obtain a high.

“In our 80-bed facility, about 50% of the admissions are of people with Tapentadol addiction. Almost 70% to 80% of them also test positive for Hepatitis C infection as they might be sharing the syringes or containers with the crushed tablets. Many are also first-time drug users and most are aged between 15 and 30 years who access it via the black market,” he said.

The move to track sales will control how much of the drug is made available, potentially discouraging new users and reducing addiction risks, he noted.

Dr Shivanna Venkataramana, senior anaesthesiologist, noted that this drug is also being used for chronic pain conditions in India, but should be used as a second line of treatment in these conditions and only on doctor’s Prescription.

“To my knowledge, there is no strict regulation of this drug in India, so this move (to track its stocks) might help curb some misuse,” he said.

Related Posts

18 maternal deaths still a ‘mystery’, says Rajasthan health minister

JAIPUR: Three months after Rajasthan first began reporting clusters of maternal fatalities at state-run hospitals, the govt has still no explanation so far of what caused the deaths of 18 women…

FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

FDA officials said the approved technical supervisor at the bank had resigned in March 2025, but blood component separation allegedly continued without an approved replacement. Pune: The Maharashtra Food and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

18 maternal deaths still a ‘mystery’, says Rajasthan health minister

18 maternal deaths still a ‘mystery’, says Rajasthan health minister

FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

Health Ministry Unveils Thalassemia Awareness Posters to Promote Early Screening

Health Ministry Unveils Thalassemia Awareness Posters to Promote Early Screening

Employees are Apples of ENTOD’s Eyes, few fall Far from Tree

Employees are Apples of ENTOD’s Eyes, few fall Far from Tree

After two years, pharma volumes pick up pace

After two years, pharma volumes pick up pace

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate